Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

'Customer data validates strategy' for cancer diagnostic, says ANGLE PLC boss Andrew Newland

Andrew Newland, founder of ANGLE PLC (LON:AGL, OTCQX:ANPCY) runs Proactive through research carried out by the University of Athens and Attikon University Hospital which has found that their Parsortix system out-performs existing technology and, for the first time, is able to harvest head and neck cancer cells from patient blood for analysis.

 
Meet Amur Minerals Corporation, Lekoil Ltd, SDX Energy Inc and Tethyan Resources PLC at our event, London, 19 October 2017. Register here »
Why Invest In ANGLE plc? Read More Here

Register here to be notified of future ANGLE plc articles
View full AGL profile View Profile

ANGLE plc Timeline

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use